NeuroVigil is at the forefront of neurotechnology with its innovative iBrain device, which revolutionizes brain monitoring by utilizing a single-channel EEG system. This portable device, smaller than a pack of cigarettes, employs three FDA-approved electrodes to capture electrical brain activity without the need for extensive wiring or invasive procedures. The iBrain is designed for ease of use, allowing individuals to wear it comfortably at home while they sleep, thus facilitating the collection of high-resolution data. The accompanying SPEARS (Sleep Parametric EEG Automated Recognition System) algorithm processes this data, creating detailed maps of brain activity that can reveal biomarkers for various neurological conditions and drug effects. This technology is not limited to sleep studies; it also has applications in monitoring awake patients, including those with severe pathologies, thereby broadening its potential impact in the field of neuroscience.

The primary goal of NeuroVigil's technology is to develop a brain-computer interface that can monitor neurological conditions, assess treatment responses, and assist individuals with severe disabilities, such as ALS, in regaining communication abilities. By focusing on collecting single-channel data from a large number of subjects, NeuroVigil aims to provide valuable insights into brain activity that can lead to faster diagnoses and more effective treatments for a range of neurological disorders. The iBrain's non-invasive nature and the ability to gather data in a familiar environment significantly enhance the research capabilities for pharmaceutical companies and academic institutions, making it a powerful tool in advancing our understanding of brain health and disease.

United States

NeuroVigil is a neurotechnology firm focused on the analysis of brain signal or electroencephalography data.

NeuroVigil

Company Details